These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 17337120)
1. Alpha-synuclein overexpression reduces gap junctional intercellular communication in dopaminergic neuroblastoma cells. Sung JY; Lee HJ; Jeong EI; Oh Y; Park J; Kang KS; Chung KC Neurosci Lett; 2007 Apr; 416(3):289-93. PubMed ID: 17337120 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of alpha-synuclein decreased viability and enhanced sensitivity to prostaglandin E(2), hydrogen peroxide, and a nitric oxide donor in differentiated neuroblastoma cells. Prasad JE; Kumar B; Andreatta C; Nahreini P; Hanson AJ; Yan XD; Prasad KN J Neurosci Res; 2004 May; 76(3):415-22. PubMed ID: 15079871 [TBL] [Abstract][Full Text] [Related]
3. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine. Moussa CE; Wersinger C; Tomita Y; Sidhu A Biochemistry; 2004 May; 43(18):5539-50. PubMed ID: 15122920 [TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. Parihar MS; Parihar A; Fujita M; Hashimoto M; Ghafourifar P Int J Biochem Cell Biol; 2009 Oct; 41(10):2015-24. PubMed ID: 19460457 [TBL] [Abstract][Full Text] [Related]
6. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage. Lev N; Melamed E; Offen D Neurosci Lett; 2006 May; 399(1-2):27-32. PubMed ID: 16584840 [TBL] [Abstract][Full Text] [Related]
7. alpha-Synuclein protects SH-SY5Y cells from dopamine toxicity. Colapinto M; Mila S; Giraudo S; Stefanazzi P; Molteni M; Rossetti C; Bergamasco B; Lopiano L; Fasano M Biochem Biophys Res Commun; 2006 Nov; 349(4):1294-300. PubMed ID: 16978583 [TBL] [Abstract][Full Text] [Related]
8. A cell-based model of alpha-synucleinopathy for screening compounds with therapeutic potential of Parkinson's disease. Zhao DL; Zou LB; Zhou LF; Zhu P; Zhu HB Acta Pharmacol Sin; 2007 May; 28(5):616-26. PubMed ID: 17439717 [TBL] [Abstract][Full Text] [Related]
9. Dual effects of alpha-synuclein on neurotoxicity induced by low dosage of rotenone are dependent on exposure time in dopaminergic neuroblastoma cells. Lu L; Gu L; Liang Y; Sun X; Duan C; Yang H Sci China Life Sci; 2010 May; 53(5):590-7. PubMed ID: 20596942 [TBL] [Abstract][Full Text] [Related]
10. Endogenous catecholamine enhances the dysfunction of unfolded protein response and alpha-synuclein oligomerization in PC12 cells overexpressing human alpha-synuclein. Ito S; Nakaso K; Imamura K; Takeshima T; Nakashima K Neurosci Res; 2010 Jan; 66(1):124-30. PubMed ID: 19835916 [TBL] [Abstract][Full Text] [Related]
11. Alpha-synuclein knockdown attenuates MPP+ induced mitochondrial dysfunction of SH-SY5Y cells. Wu F; Poon WS; Lu G; Wang A; Meng H; Feng L; Li Z; Liu S Brain Res; 2009 Oct; 1292():173-9. PubMed ID: 19646423 [TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis. Alberio T; Bossi AM; Milli A; Parma E; Gariboldi MB; Tosi G; Lopiano L; Fasano M FEBS J; 2010 Dec; 277(23):4909-19. PubMed ID: 20977677 [TBL] [Abstract][Full Text] [Related]
13. Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant alpha-synuclein. Zhou ZD; Yap BP; Gung AY; Leong SM; Ang ST; Lim TM Exp Cell Res; 2006 Jan; 312(2):156-70. PubMed ID: 16297908 [TBL] [Abstract][Full Text] [Related]
14. Oxidative stress induces nuclear translocation of C-terminus of alpha-synuclein in dopaminergic cells. Xu S; Zhou M; Yu S; Cai Y; Zhang A; Uéda K; Chan P Biochem Biophys Res Commun; 2006 Mar; 342(1):330-5. PubMed ID: 16480958 [TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein enhances dopamine D2 receptor signaling. Kim SJ; Kim SY; Na YS; Lee HJ; Chung KC; Baik JH Brain Res; 2006 Dec; 1124(1):5-9. PubMed ID: 17087919 [TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation. Shaikh S; Nicholson LF J Neurosci Res; 2008 Jul; 86(9):2071-82. PubMed ID: 18335520 [TBL] [Abstract][Full Text] [Related]
17. Connexin 32 and its derived homotypic gap junctional intercellular communication inhibit the migration and invasion of transfected HeLa cells via enhancement of intercellular adhesion. Yang J; Liu B; Wang Q; Yuan D; Hong X; Yang Y; Tao L Mol Med Rep; 2011; 4(5):971-9. PubMed ID: 21687945 [TBL] [Abstract][Full Text] [Related]
18. [Overexpression of alpha-synuclein in SH-SY5Y cells partially protected against oxidative stress induced by rotenone]. Liu YY; Zhao HY; Zhao CL; Duan CL; Lu LL; Yang H Sheng Li Xue Bao; 2006 Oct; 58(5):421-8. PubMed ID: 17041725 [TBL] [Abstract][Full Text] [Related]
19. Microarray expression analysis of human dopaminergic neuroblastoma cells after RNA interference of SNCA--a key player in the pathogenesis of Parkinson's disease. Häbig K; Walter M; Stappert H; Riess O; Bonin M Brain Res; 2009 Feb; 1256():19-33. PubMed ID: 19135032 [TBL] [Abstract][Full Text] [Related]
20. Connexins and their channels in cell growth and cell death. Vinken M; Vanhaecke T; Papeleu P; Snykers S; Henkens T; Rogiers V Cell Signal; 2006 May; 18(5):592-600. PubMed ID: 16183253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]